Renan Domingues

Prof. Dr. Renan Domingues

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
RDRenan Barros Domingues
Renan Barros Domingues
GKGustavo W. Kuster
Gustavo W. Kuster
FOFábio L. Onuki-Castro
Fábio L. Onuki-Castro
VSVanda A. Souza
Vanda A. Souza
JLJosé E. Levi
José E. Levi
CPCláudio S. Pannuti
Cláudio S. Pannuti

1 May 1998 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
RDRenan Barros Domingues
Renan Barros Domingues
MFM.C.D Fink
M.C.D Fink
ATA.M.C Tsanaclis
A.M.C Tsanaclis
CCC.C de Castro
C.C de Castro
GCG.G Cerri
G.G Cerri
FLF.D Lakeman
F.D Lakeman

20 June 2020 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
RDRenan Barros Domingues
Renan Barros Domingues
MMMaria Cássia Mendes-Correa
Maria Cássia Mendes-Correa
FLFernando Brunale Vilela de Moura Leite
Fernando Brunale Vilela de Moura Leite
ESEster Cerdeira Sabino
Ester Cerdeira Sabino
DSDiego Zanotti Salarini
Diego Zanotti Salarini
CSCarlos Augusto Senne Soares
Carlos Augusto Senne Soares
The association between coronaviruses and central nervous system (CNS) demyelinating lesions has been previously shown. However, no case has been described of an association between the novel coronavirus (SARS-COV-2) and CNS demyelinating disease so far. SARS-COV-2 was previously detected in cerebrospinal fluid (CSF) sample of a patient with encephalitis. However, the virus identity was not confirmed by deep sequencing of SARS-COV-2 detected in the CSF. Here, we report a case of a patient with mild respiratory symptoms and neurological manifestations compatible with clinically isolated syndrome. The viral genome of SARS-COV-2 was detected and sequenced in CSF with 99.74–100% similarity between the patient virus and worldwide sequences. This report suggests a possible association of SARS-COV-2 infection with neurological symptoms of demyelinating disease, even in the absence of relevant upper respiratory tract infection signs.

1 July 1997 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
RDRenan Barros Domingues
Renan Barros Domingues
ATAna Maria C. Tsanaclis
Ana Maria C. Tsanaclis
CPClaudio S. Pannuti
Claudio S. Pannuti
MMMatthew S. Mayo
Matthew S. Mayo
FLFred D. Lakeman
Fred D. Lakeman
Detection of DNA from herpes simplex virus in cerebrospinal fluid (CSF) samples by polymerase chain reaction (PCR) analysis has been shown to be more

17 June 2010 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
MTMarco Túlio A. Tanure
Marco Túlio A. Tanure
RGRodrigo S. Gomez
Rodrigo S. Gomez
RHRubens Carlos L. Hurtado
Rubens Carlos L. Hurtado
Antonio TeixeiraAntonio Teixeira
Antonio Teixeira
RDRenan Barros Domingues
Renan Barros Domingues
There is a growing body of evidence implicating inflammatory cytokines and brain-derived neurotropic factor (BDNF) in the generation of migraine pain. No previous study evaluated BNDF levels during migraine attacks and there are conflicting results regarding tumor necrosis factor-alpha (TNF-alpha) serum levels. This study compared serum levels of TNF-alpha, soluble TNF receptors 1 and 2 (sTNF-R1 and sTNF-R2), and BDNF during migraine attacks and in headache-free periods. Nine patients with episodic migraine were clinically evaluated during a migraine attack and in a headache-free period. Blood sample of each patient in both occasions was collected and all serum was submitted to TNF-alpha, sTNF-R1, sTNF-R2, and BDNF determination by ELISA. There was no significant difference in the serum levels of TNF-alpha, sTNF-R1 and sTNF-R2 in migraine attack period and headache-free period. BDNF serum levels were significantly higher during migraine attack than in pain-free period. This is the first report showing that BDNF serum levels increase during migraine attack. This reinforces the view that BDNF may be implicated in the physiopathology of migraine.

1 June 2012 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
CACaroline Martins de Araújo
Caroline Martins de Araújo
IBIzabela Guimarães Barbosa
Izabela Guimarães Barbosa
SLStela Maris Aguiar Lemos
Stela Maris Aguiar Lemos
RDRenan Barros Domingues
Renan Barros Domingues
Antonio TeixeiraAntonio Teixeira
Antonio Teixeira
Patients with migraine often report cognitive complaints, especially regarding attention and memory. Objective: To perform a systematic review of the studies available on cognitive evaluation in patients with migraine. Methods: We evaluated all articles containing the key words: "Migraine", "Cognition" and "Cognitive Impairment." Results: The search strategy resulted in 23 articles. Fifteen out of the 23 studies (65.3%) retrieved reported abnormalities on neuropsychological tests in migraine patients, notably tests of memory, attention and information processing speed. Most of the studies showing cognitive changes in migraine were carried out in neurological care facilities. Conversely, among community-based studies, migraine patients were less likely to present cognitive changes. Conclusion: Patients with migraine, especially those followed at neurology clinics, show an elevated risk of mild changes in several cognitive domains. Further studies with greater methodological refinement are warranted in order to clearly establish whether this cognitive dysfunction is associated with an underlying migraine pathophysiological process.